| CDE ID | CDE Description | | * 421 | EDRN Participant ID (Go To: 774) |
| * 774 | Date of surgery (MM/DD/YYYY): (Go To: 423) |
| * 423 | EDRN Protocol ID (Go To: 422) |
| * 422 | EDRN Site ID (Go To: 929) |
| * 929 | EDRN Staff ID of the person who collected the data: (Go To: 1219) |
| * 1219 | Date of contact (MM/DD/YYYY): (Go To: 844) |
| * 844 | Date pathology report completed (MM/DD/YYYY): (Go To: 4923) |
| * 4923 | Type of surgery (gynecological) Check all that apply (Go To: 4911) |
| | | Permissible Values (value): | Hysterectomy, NOS (7) |
|
| | | | Diagnostic laparoscopy (10) |
|
| | | | Diagnostic laparoscopy with biopsy (11) |
|
| | | | Pelvic washing or collection of ascites (12) |
|
| | | | Unilateral salpingoophorectomy (13) |
|
| | | | Bilateral salpingoophorectomy (BSO) (14) |
|
| | | | Omental biopsy/omentectomy (15) |
|
| | | | Excision of lymph nodes (16) |
|
| | |
| | |
| | | | Unilateral ovarian cystectomy (19) |
|
| | | | Bilateral ovarian cystectomy (20) |
|
| | | | Other, specify: (97) (Go To: 3226) |
|
| * 3226 | Surgery type (Other, specify): (Go To: 4911) |
| * 4911 | Estimated blood loss during surgery, mL (Go To: 4886) |
| * 4886 | Gynocological surgery results (Go To: 4989) |
| | | Permissible Values (value): | Primary fallopian tube cancer (1) (Go To: 4870) |
|
| | | | Tubal intraepithelial cancer (TIC) (2) (Go To: 4870) |
|
| | | | Primary ovarian cancer (3) (Go To: 4870) |
|
| | | | Primary peritoneal cancer (PPC) (4) (Go To: 4870) |
|
| | | | Borderline cancer (10) (Go To: 4870) |
|
| | |
| | | | Ovary and fallopian tubes without pathology abnormality (7) (Go To: 1097) |
|
| | | | Metastasis to adnexa from other primary site (9) |
|
| | | | Other, specify: (97) (Go To: 4890) |
|
| | | | Unknown (99) (Go To: 1097) |
|
| * 4890 | Gynecological surgery results (Other, specify) (Go To: 4989) |
| * 4917 | Was the surgical resection optimal? (Go To: 4891) |
| | | Permissible Values (value): | No (0) |
|
| | |
| | |
| * 4891 | Residual disease volume (Go To: 4870) |
| | | Permissible Values (value): | No gross residual (0) |
|
| | | | Visible residual disease < 1 cm in size (1) |
|
| | | | Residual Disease >= 1 cm in size (2) |
|
| | |
| * 4870 | Ovary T-Stage, pathologic (Go To: 4871) |
| | | Permissible Values (value): | TX (0) |
|
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| * 4871 | Ovary N-Stage, pathologic (Go To: 4872) |
| | | Permissible Values (value): | NX (0) |
|
| | |
| | |
| | |
| | |
| | |
| * 4872 | Ovary M-Stage, pathologic (Go To: 758) |
| | | Permissible Values (value): | MX (0) |
|
| | |
| | |
| | |
| | |
| | |
| * 758 | Histologic grade (WHO): (Go To: 4989) |
| | | Permissible Values (value): | Grade 1 (G1) (1) |
|
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| * 4989 | Pathology findings, short list (Go To: 4916) |
| | | Permissible Values (value): | None (0) |
|
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| * 4916 | WHO 2014 classification of tumours of the ovary; description (Go To: 4904) |
| | | Permissible Values (value): | Not applicable (0) |
|
| | | | Serous tumors, Serous cystadenoma (8441/0) (1) |
|
| | | | Serous tumors, Serous adenofibroma (9014/0) (2) |
|
| | | | Serous tumors, Serous surface papilloma (8461/0) (3) |
|
| | | | Serous tumors, Serous borderline tumor/Atypical proliferative serous tumor (8442/1) (4) |
|
| | | | Serous tumors, Serous borderline tumor-micropapillary variant/non-invasive low-grade (8460/2) (5) |
|
| | | | Serous tumors, Low-grade serous carcinoma (8460/3) (6) |
|
| | | | Serous tumors, High-grade serous carcinoma (8461/3) (7) |
|
| | | | Mucinous tumors, Mucinous cystadenoma (8470/0) (8) |
|
| | | | Mucinous tumors, Mucinous adenofibroma (9015/0) (9) |
|
| | | | Mucinous tumors, Mucinous borderline tumor/Atypical proliferative mucinous tumor (8472/1) (10) |
|
| | | | Mucinous tumors, Mucinous carcinoma (8480/3) (11) |
|
| | | | Endometrioid tumors, Endometriotic cyst (12) |
|
| | | | Endometrioid tumors, Endometriotic cystadenoma (8380/0) (13) |
|
| | | | Endometrioid tumors, Endometriotic adenofibroma (8381/0) (14) |
|
| | | | Endometrioid tumors, Endometroid borderline tumor/Atypical proliferative endometrioid tumor (8380/1) (15) |
|
| | | | Endometrioid tumors, Endometroid carcinoma (8380/3) (16) |
|
| | | | Clear cell tumors, Clear cell cystadenoma (8443/0) (17) |
|
| | | | Clear cell tumors, Clear cell adenofibroma (8313/0) (18) |
|
| | | | Clear cell tumors, Clear cell borderline tumor/Atypical proliferative clear cell tumor (8313/1) (19) |
|
| | | | Clear cell tumors, Clear cell carcinoma (8310/3) (20) |
|
| | | | Brenner tumors, Brenner tumor (9000/0) (21) |
|
| | | | Brenner tumors, Borderline Brenner tumor/Atypical proliferative Brenner tumor (9000/1) (22) |
|
| | | | Brenner tumors, Malignant Brenner tumor (9000/3) (23) |
|
| | | | Seromucinous tumors, Seromucinous cystadenoma (8474/0) (24) |
|
| | | | Seromucinous tumors, Seromucinous adenofibroma (9014/0) (25) |
|
| | | | Seromucinous tumors, Seromucinous borderline tumor/Atypical proliferative seromucinous tumor (8474/1) (26) |
|
| | | | Seromucinous tumors, Seromucionous carcinoma (8474/3) (27) |
|
| | | | Mesenchymal tumors, Low-grade endometroid stromal sarcoma (8931/3) (29) |
|
| | | | Mesenchymal tumors, High-grade endometroid stromal sarcoma (8930/3) (30) |
|
| | | | Mixed epithelial and mesenchymal tumors, Adenosarcoma (8933/3) (31) |
|
| | | | Mixed epithelial and mesenchymal tumors, Carcinosarcoma (8980/3) (32) |
|
| | | | Sex cord-stromal tumors, Fibroma (8810/0) (33) |
|
| | | | Sex cord-stromal tumors, Cellular fibroma (8810/1) (34) |
|
| | | | Sex cord-stromal tumors, Thecoma (8600/0) (35) |
|
| | | | Sex cord-stromal tumors, Luteinized thecoma associated with sclerosing peritonitis (8601/0) (36) |
|
| | | | Sex cord-stromal tumors, Fibrosarcoma (8810/3) (37) |
|
| | | | Sex cord-stromal tumors, Sclerosing stromal tumor (8602/0) (38) |
|
| | | | Sex cord-stromal tumors, Signet-ring stromal tumor (8590/0) (39) |
|
| | | | Sex cord-stromal tumors, Microcystic stromal tumor (8590/0) (40) |
|
| | | | Sex cord-stromal tumors, Leydig cell tumor (8650/0) (41) |
|
| | | | Sex cord-stromal tumors, Steroid cell tumor (8760/0) (42) |
|
| | | | Sex cord-stromal tumors, Steroid cell tumor, malignant (8760/3) (43) |
|
| | | | Sex cord-stromal tumors, Adult granulosa cell tumor (8620/3) (44) |
|
| | | | Sex cord-stromal tumors, Juvenile granulosa cell tumor (8622/1) (45) |
|
| | | | Sex cord-stromal tumors, Sertoli cell tumor (8640/1) (46) |
|
| | | | Sex cord-stromal tumors, Sex cord tumor with annular tubules (8623/1) (47) |
|
| | | | Sex cord-stromal tumors, NOS (8590/1) (55) |
|
| | | | Germ cell tumors, Dysgerminoma (9060/3) (56) |
|
| | | | Germ cell tumors, Yok sac tumor (9071/3) (57) |
|
| | | | Germ cell tumors, Embryonal carcinoma (9070/3) (58) |
|
| | | | Germ cell tumors, Non-gestational choriocarcinoma (9100/3) (59) |
|
| | | | Germ cell tumors, Mature teratoma (9080/0) (60) |
|
| | | | Germ cell tumors, Immature teratoma (9080/0) (61) |
|
| | | | Germ cell tumors, Mixed germ cell tumor (9085/3) (62) |
|
| | | | Monodermal teratoma and somatic-type tumors.., Struma ovarii, benign (9090/0) (63) |
|
| | | | Monodermal teratoma and somatic-type tumors.., Struma ovarii, malignant (9090/3) (64) |
|
| | | | Monodermal teratoma and somatic-type tumors.., Carcinoid (8240/3) (65) |
|
| | | | Monodermal teratoma and somatic-type tumors.., Strumal carcinoid (9091/1) (66) |
|
| | | | Monodermal teratoma and somatic-type tumors.., Mucinous carcinoid (8243/3) (67) |
|
| | | | Monodermal teratoma and somatic-type tumors.., Neuroectodermal-type tumors (68) |
|
| | | | Monodermal teratoma and somatic-type tumors.., Sebaceous adenoma (8410/0) (69) |
|
| | | | Monodermal teratoma and somatic-type tumors.., Sebaceous carcinoma (8410/3) (70) |
|
| | | | Monodermal teratoma and somatic-type tumors.., Other rare mondermal teratomas (71) |
|
| | | | Monodermal teratoma and somatic-type tumors.., Carcinomas, Squamous cell carcinoma (8070/3) (72) |
|
| | | | Monodermal teratoma and somatic-type tumors.., Carcinomas, Others (73) |
|
| | | | Germ cell - sex cord-stromal tumors, Gonadoblastoma, including gonadoblastoma with malignant germ cell tumor (9073/1) (74) |
|
| | | | Germ cell - sex cord-stromal tumors, Mixed germ cell-sex cord-stromal tumor, unclassified (8594/1) (75) |
|
| | | | Miscellaneous tumors, Adenoma of rete ovarii (9110/0) (76) |
|
| | | | Miscellaneous tumors, Adenocarcinoma of rete ovarii (9110/3) (77) |
|
| | | | Miscellaneous tumors, Wolffian tumor (9110/1) (78) |
|
| | | | Miscellaneous tumors, Small cell carcinoma, hypercalcemic type (8044/3) (79) |
|
| | | | Miscellaneous tumors, Small cell carcinoma, pulmonary type (8041/3) (80) |
|
| | | | Miscellaneous tumors, Wilms tumor (8960/3) (81) |
|
| | | | Miscellaneous tumors, Paraganglioma (8693/1) (82) |
|
| | | | Miscellaneous tumors, Solid pseudopapillary neoplasm (8452/1) (83) |
|
| | | | Mesothelial tumors, Adenomatoid tumor (9054/0) (84) |
|
| | | | Mesothelial tumors, Mesothelioma (9050/3) (85) |
|
| | | | Soft tissue tumors, Myxoma (8840/0) (86) |
|
| | | | Soft tissue tumors, Others (87) |
|
| | | | tumor-like lesions, Follicle cyst (88) |
|
| | | | tumor-like lesions, Corpus luteum cyst (89) |
|
| | | | tumor-like lesions, Large solitary luteinized follicle cyst (90) |
|
| | | | tumor-like lesions, Hyperreactio luteinalis (91) |
|
| | | | tumor-like lesions, Pregnancy luteoma (92) |
|
| | | | tumor-like lesions, Stromal hyperplasia (93) |
|
| | | | tumor-like lesions, Stromal hyperthecosis (94) |
|
| | | | tumor-like lesions, Fibromatosis (95) |
|
| | | | tumor-like lesions, Massive oedema (96) |
|
| | | | tumor-like lesions, Leydig cell hyperplasia (97) |
|
| | | | tumor-like lesions, Others (98) |
|
| | | | Lymphoid and myeloid tumors, Lymphomas (99) |
|
| | | | Lymphoid and myeloid tumors, Plasmacytoma (9734/3) (100) |
|
| | | | Lymphoid and myeloid tumors, Myeloid neoplasms (101) |
|
| * 4904 | WHO 2014 classification of tumours of the ovary; code (Go To: 4912) |
| * 4912 | Benign ovarian findings (Go To: 4914) |
| | | Permissible Values (value): | None (0) |
|
| | | | Endometriosis/endometrioma (1) |
|
| | | | Benign ovarian cysts (serous or mucinous) including cystadenofibroma (2) |
|
| | |
| | |
| | | | Hemorrhagic corpus luteal cyst/follicular cyst (5) |
|
| | | | Other, specify: (97) (Go To: 4913) |
|
| * 4913 | Benign ovarian findings, (other, specify) (Go To: 4914) |
| * 4914 | Fallopian tube findings (Go To: 2226) |
| | | Permissible Values (value): | None (0) |
|
| | | | STIC (serous tumor intraepithelial carcinoma) (Ki-67 > 10%, p53 staining compatible with a mutation pattern either missense or deletion) (1) |
|
| | | | STIL (serous tubal intraepithelial lesion) (low Ki-67 < 10%, p53 staining compatible with a mutation pattern either missense or deletion) (2) |
|
| | | | p53 signature (morphologically normal + p53 missense mutation pattern) (3) |
|
| | | | Unremarkable (p53 wild-type pattern, Ki-67 < 10%) (4) |
|
| | | | Other, specify: (97) (Go To: 4915) |
|
| * 4915 | Fallopian tube findings (other, specify) (Go To: 2226) |
| * 2226 | Lymph nodes removed? (Go To: 3840) |
| | | Permissible Values (value): | No (0) |
|
| | |
| | |
| * 3840 | Provider medical specialty (Go To: 1097) |
| | | Permissible Values (value): | General surgery (4) |
|
| | |
| | | | Obstetrics and gynecology (7) |
|
| | | | Gynecologic oncologist (37) |
|
| | | | Minimally Invasive Gynecologic Surgeon (MIGS) (38) |
|
| | | | Other, specify: (97) (Go To: 3959) |
|
| | |
| * 3959 | Provider medical specialty (other, specify) (Go To: 1097) |
| 1097 | Comments (do not include any participant identifiers) (Go To: End of Form) |